The cost and benefits of myopia management
Key points
- Controlling myopia progression helps children enjoy clear, consistent vision and less eye strain.
- Lower levels of myopia lead to a decreased chance of serious eye complications, which can be financially and emotionally burdensome in the long run.
- Stable myopia means longer intervals between prescription updates, ultimately reducing eyewear costs over time.
In this article:
This article will explore the cost versus benefit of managing myopia, highlighting the ways that it can correct and preserve your child’s eyesight, saving hassle and expense in the long-term.
Why myopia is more than just glasses
Imagine your child who has been struggling to see distant objects has just been diagnosed with myopia (nearsightedness). Their newly prescribed glasses have instantly improved their distance vision. But a year later? Your child is squinting to see again and their prescription has now doubled. Alarmingly, this is becoming an increasingly common situation, as more young people in the world are developing myopia.
Did you know? Over the past 50 years, the percentage of 10-16 year olds with myopia in the UK has more than doubled, and children are now developing myopia at younger ages.
Myopia comes from uncontrolled eye growth and tends to progress in school aged children.
Standard, single vision glasses or contact lenses offer a short-term fix, like plugging a small hole in a sinking boat: it keeps the immediate problem at bay but doesn’t prevent new leaks from forming. To learn more about myopia, see What is myopia?.
Myopia management – how to take care of your child’s myopia the right way
Definition
Myopia management is the evidence-based standard of care that encompasses the eye examination, prescription, treatment and follow-up of myopia across a person’s lifespan. Eye care guidelines and professional bodies in optometry and ophthalmology recognize the importance of actively managing myopia.
The World Council of Optometry Standard of Care for Myopia Management by Optometrists (2021), explains myopia management as: “optometrists addressing patients’ needs of today by correcting myopia, while also providing evidence-based interventions (e.g., contact lenses, spectacles, pharmaceuticals) that slow the progression of myopia, for improved quality of life and better eye health and into the future”.
Treating myopia
Research has come a long way into developing treatments to combat myopia – called ‘myopia control’. The options for myopia control in children and teenagers include specialty glasses lenses, soft contact lenses (e.g. dual focus contact lenses), orthokeratology (ortho-k) and atropine eye drops. Each of these categories has effective options for slowing down progression.
To learn more about myopia control, see What is myopia control and why it is important, and to understand which option is best for your child, see Which is the best option for myopia control?.
Eye care has also shifted from simply correcting vision to a more proactive and holistic approach. Eye care practitioners are also equipped to discuss the ways to manage your child’s myopia through lifestyle changes. A child or teenager's vision, eye health and general health can be influenced by their visual environment - how much time they spend outdoors
Benefits of myopia management
Making well-informed decisions to treat your child’s myopia progression can bring everyday benefits that last a lifetime. Let’s explore three key benefits of myopia management.
Stress-free daily life
A significant yet often overlooked perk of myopia management is its impact on a child’s daily vision. When myopia remains mild or progresses more slowly your child can perform their usual daily activities with more ease and comfort. New glasses and stronger prescriptions may be accompanied by a period of eye strain, which can last up to 4 weeks.
Activities that require clear vision and coordination like sports or dance become easier with less severe myopia.
Preserving healthy vision
Myopia management is arguably more rewarding in the long-term than short-term, because every step in prescription that is slowed translates to a step in vision saved. As myopia worsens, the eyeball elongates, stretching the retina and other delicate tissues. This renders the eye vulnerable to developing serious eye diseases later in life, such as retinal detachment.
Higher levels of myopia weaken the macula and amplify the risk of myopic macular degeneration, resulting in permanent blind spots and damage to vision.
Each of these disorders carries considerable burden—financial, emotional, and practical—affecting a person’s independence and quality of life. Slowing progression is an investment towards preserving a child’s eye health when they’re older, sparing them from future medical procedures or complications. Even a modest reduction in final prescription equates to a noteworthy decrease in the likelihood of these vision-threatening issues.
Lower level of final myopia
Starting early offers the best opportunity to shape lifelong vision as well as eye health. In children who have been initially diagnosed, the myopia tends to get worse.
The aim of myopia management is to minimize or prevent myopia progression. More years of myopia control treatment are likely to result in less final amount of myopia once the child becomes older.
Every child with myopia under age 16 is likely to show progression or worsening, so we should not wait to first see if they progress - we should start myopia control treatment as soon as possible. We should be especially proactive for children under 12, who are in their fastest phase of myopia progression.
Costs of myopia management
Specialty lenses cost more to fit and manufacture compared to standard lenses, and atropine eye drops involve recurring medication expenses.
Comparing the costs
Experts concluded in 2022 that across a person’s lifetime, myopia management is generally better value-for-money than wearing standard single-vision correction (no treatment).
The graphs below show how these costs compare.
Why myopia management ends up the cheaper option
To understand where the cost savings lie in myopia control, consider the pitfalls from only wearing traditional correction. Children wearing traditional correction will experience steadily worsening prescriptions, leading to frequent updates in glasses or contact lens strengths. If the child progresses to moderate or high myopia, more expensive or technical lenses are required to keep maintain clear and comfortable vision.
The early costs of myopia management options are easily balanced across a lifetime by less myopia progression, fewer lens replacements, reduced need for premium lenses later in life, reduced risk of eye disease and vision loss, and reduced eye complications from myopia.
Weighing the costs and benefits
At first glance, myopia management appears to be pricier than standard correction. The availability and costs of different treatments will vary between countries; but in general, myopia control carries higher upfront costs compared to standard single vision lenses.
While there may be ongoing costs in starting myopia management, these pay off with the long-term savings linked to slower prescription increases and reduced risk of expensive surgical treatments later in life.
Discuss your child’s vision needs and lifestyle with your optometrist or eye doctor, to identify which myopia management method will be the most suitable for your child.
References
- McCullough SJ, O'Donoghue L, Saunders KJ. Six Year Refractive Change among White Children and Young Adults: Evidence for Significant Increase in Myopia among White UK Children. PLoS One. lug 2026;11(1):e0146332. [link]
- Fricke TR, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. mag 2016;123(5):1036-42. [link]
- Donovan L, Sankaridurg P, Ho A, et al. Myopia progression rates in urban children wearing single-vision spectacles. Optom Vis Sci. gen 2012;89(1):27-32. [link]
- Saw SM, Gazzard G, Shih-Yen EC, et al. Myopia and associated pathological complications. Ophthalmic Physiol Opt. set 2005;25(5):381-91. [link]
- Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. nov 2012;31(6):622-60. [link]
- Hendicott PL, Block SS. How the World Council of Optometry produced new guidelines for myopia management. Community Eye Health. lug 2026;35(117):21-22. [link]
- Xiong S, Sankaridurg P, Naduvilath TJ, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. set 2017;95(6):551-566. [link]
- Deng L, Pang Y. Effect of Outdoor Activities in Myopia Control: Meta-analysis of Clinical Studies. Optom Vis Sci. apr 2019;96(4):276-282. [link]
- Yang GY, Huang LH, Schmid KL, et al. Associations Between Screen Exposure in Early Life and Myopia amongst Chinese Preschoolers. Int J Environ Res Public Health. feb 2020;17(3). [link]
- Li SM, Li SY, Kang MT, et al. Near Work Related Parameters and Myopia in Chinese Children: the Anyang Childhood Eye Study. PLoS One. nov 2025;10(8):e0134514. [link]
Nisar H, Latif B, Awan MA, Din SFU, Bashir T. Adaptation time required after change in astigmatic prescription as compared to spherical prescription in teenagers. 2018 Oct 1;8:7–11.
[link]- Rose KA, Harper R, Tromans C, et al. Quality of life in myopia. Br J Ophthalmol. set 2000;84(9):1031-4. [link]
- Wong YL, Sabanayagam C, Ding Y, et al. Prevalence, Risk Factors, and Impact of Myopic Macular Degeneration on Visual Impairment and Functioning Among Adults in Singapore. Invest Ophthalmol Vis Sci. set 2018;59(11):4603-4613. [link]
- Mitchell P, Hourihan F, Sandbach J, et al. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. ott 1999;106(10):2010-5. [link]
- Kanthan GL, Mitchell P, Rochtchina E, et al. Myopia and the long-term incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Clin Exp Ophthalmol. lug 2026;42(4):347-53. [link]
- Bullimore MA, Brennan NA. Myopia Control: Why Each Diopter Matters. Optom Vis Sci. giu 2019;96(6):463-465. [link]
- Bullimore MA, Richdale K. Myopia Control 2020: Where are we and where are we heading?. Ophthalmic Physiol Opt. mag 2020;40(3):254-270. [link]
- Brennan NA, Toubouti YM, Cheng X, et al. Efficacy in myopia control. Prog Retin Eye Res. lug 2021;83:100923. [link]
- Jones L, Drobe B, González-Méijome JM, et al. IMI - Industry Guidelines and Ethical Considerations for Myopia Control Report. Invest Ophthalmol Vis Sci. feb 2019;60(3):M161-M183. [link]
- Fricke TR, Sankaridurg P, Naduvilath TJ, et al. Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia. Br J Ophthalmol. ago 2023;107(8):1043-1050. [link]
- Modjtahedi BS, Abbott RL, Fong DS, et al. Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children: The Academy's Task Force on Myopia. Ophthalmology. giu 2021;128(6):816-826. [link]